Physician
Hematology
Dr. Timothy J. O'Rourke, MD
|
|
Give Review
Dr. Timothy J. O'Rourke is an expert in the field of Hematology. He attended University of Michigan Medical School. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Timothy J. O'Rourke is a published doctor and has 22 publications published. The lastest was: 'Phase II trial of paclitaxel by 24-hour continuous infusion for relapsed non-Hodgkin's lymphomas: Southwest Oncology Group trial 9246.'
Publications
- Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma.
- Reduced time for urinary alkalinization before high-dose methotrexate With preadmission oral bicarbonate.
- Phase II trial to evaluate gemcitabine and etoposide for locally advanced or metastatic pancreatic Cancer.
- Cost savings from dose rounding of biologic antiCancer agents in adults.
- Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate Cancer.
- Locally advanced prostate Cancer treated with concomitant radiation and 5-fluorouracil: Southwest Oncology Group Study 9024.
- Phase 1b study of motesanib, an oral angiogenesis inhibitor, in combination with carboplatin/paclitaxel and/or panitumumab for the treatment of advanced non-small Cell...
- Phase II trial of paclitaxel by 24-hour continuous infusion for relapsed non-Hodgkin's Lymphomas: Southwest Oncology Group trial 9246.
- A phase I clinical and pharmacokinetic study of the topoisomerase I inhibitor topotecan (SK&F 104864) given as an intravenous bolus every 21 days.
- Interobserver variability in prostate Cancer specific survival.
- New antiCancer agents.
- Phase I clinical trial of ormaplatin (tetraplatin, NSC 363812).
- A randomized trial of two schedules of trimetrexate versus 5-fluorouracil in advanced colorectal Cancer: a Southwest Oncology Group study.
- Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days.
- Improvements in clinical benefit with vinorelbine in the treatment of hormone-refractory prostate Cancer: a phase II trial.
- Prolonged, alternating chemotherapy for extensive small cell lung Cancer. A Southwest oncology Group study.
- Extended administration of oral etoposide and oral cyclophosphamide for the treatment of advanced non-small-cell lung Cancer: a Southwest Oncology Group study.
- Phase II trial of recombinant DNA gamma-interferon in advanced colorectal Cancer: a Southwest Oncology Group study.
- Phase II evaluation of recombinant gamma-interferon in patients with advanced pancreatic Carcinoma: a Southwest Oncology Group study.
- Phase I clinical and pharmacokinetic trial of Brequinar sodium (DuP 785; NSC 368390).
- Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: a phase II trial of the Minnie pearl Cancer research network.
Schools
University Of Michigan Medical School
Madigan Amc
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Geriatric Medicine
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Madigan Healthcare System -
University of Michigan Medical School
Hospital
-
Spectrum Health - Butterworth Hospital
Drug Facts
| NPI NUMBER | 1215938303 | |
| NPPES Provider LastName | O'ROURKE | |
| NPPES Provider FirstName | TIMOTHY | |
| NPPES Provider ZIPCode | 495032562 | |
| NPPES Provider State | MI | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 2201.0 | |
| Distinct Opioid Count | 9.0 | |
| Opioid Claim Count | 480.0 | |
| Percent Opioid Claims | 21.81 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1215938303 |
| Last Name Of The Provider | O'ROURKE |
| First Name Of The Provider | TIMOTHY |
| View All |
Similar Doctors
|
|
Dr. Ronald Rop, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cynthia Ochs, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kimberly A. Baptiste, MD |
|
|
Dr. Terrell K. Hebert, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hikmet H. Sipahi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas Hall, MD |
|
|
Dr. Joan E. Nagelkirk, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark G. Campbell, MD |
|
|
Dr. Oluwatoyin Thomas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Casey J. Cress, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zackery Y. Zhang, MD |